Here, we found that the 20% elongation group significantly decreased AF cell proliferation potency, aggravated G0/G1 cell cycle arrest, decreased telomerase activity, and upregulated gene and protein expression of p16 and p53. The gene discussed is TP53; the disease is atrial fibrillation.